Dutch Village Road construction frustrates shop owner
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Lightspeed Commerce reports US$49.6 million loss in Q1, revenue US$304.9 million
MONTREAL — Lightspeed Commerce Inc. says it lost US$49.6 million in its first quarter of 2026 compared with a net loss of US$35 million in the same quarter last year. The Montreal-based company says on an adjusted basis, it made US$7.9 million in the quarter compared to US$16.1 million in the period last year. Adjusted net income for the period ended June 30 worked out to six cents per diluted share, compared to 10 cents per diluted share last year. It says revenue totalled US$304.9 million, up from US$266.1 million last year. The company says it added 1,700 customer locations across retail in North America and hospitality in Europe to make for five per cent growth from the previous year. Lightspeed says it expects revenue growth of between 10 and 12 per cent for its 2026 fiscal year. This report by The Canadian Press was first published July 31, 2025. Companies in this story: (TSX:LSPD) The Canadian Press
Yahoo
28 minutes ago
- Yahoo
Baron Health Care Fund Reacquired Edwards Lifesciences Corporation (EW) in Q2. Here's Why
Baron Funds, an investment management company, released its 'Baron Health Care Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a challenging backdrop for the broader Health Care sector, compared to a 6.19% decline for the Russell 3000 Health Care Index (benchmark) and a 10.99% gain for the Russell 3000 Index (the Index). In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Baron Health Care Fund highlighted stocks such as Edwards Lifesciences Corporation (NYSE:EW). Edwards Lifesciences Corporation (NYSE:EW) offers products and technologies for structural heart disease and critical care monitoring. The one-month return of Edwards Lifesciences Corporation (NYSE:EW) was 5.69%, and its shares gained 31.20% of their value over the last 52 weeks. On July 30, 2025, Edwards Lifesciences Corporation (NYSE:EW) stock closed at $81.16 per share, with a market capitalization of $47.608 billion. Baron Health Care Fund stated the following regarding Edwards Lifesciences Corporation (NYSE:EW) in its second quarter 2025 investor letter: "We reacquired shares of Edwards Lifesciences Corporation (NYSE:EW), a leading manufacturer of heart valve replacement and repair products. Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to treat aortic stenosis, a disease that obstructs the flow of blood out of the aortic valve, which strains the heart. Edwards Lifesciences has a leading position in the TAVR market backed by a robust body of clinical evidence and physician familiarity with the product and workflow. TAVR is a $5 billion market that still continues to grow many years after Edwards Lifesciences first entered the market. We expect this growth to continue at a moderate pace as indications expand to cover a broader patient population. In addition, competitor Boston Scientific Corporation recently exited the TAVR market, which provides incremental market share opportunity for Edwards Lifesciences. A skilled surgeon surrounded by a team of medical professionals performing a Transcatheter Heart Valve Replacement. Edwards Lifesciences Corporation (NYSE:EW) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 63 hedge fund portfolios held Edwards Lifesciences Corporation (NYSE:EW) at the end of the first quarter, which was 67 in the previous quarter. Edwards Lifesciences Corporation (NYSE: EW) reported total sales of $1.53 billion in Q2 2025, reflecting a growth of 10.6%, which exceeded expectations. While we acknowledge the potential of Edwards Lifesciences Corporation (NYSE:EW) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we discussed Edwards Lifesciences Corporation (NYSE:EW) and shared Jim Cramer's latest thoughts. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
28 minutes ago
- Yahoo
Gildan Activewear Inc. reports US$137.9 million profit for second quarter
MONTREAL — Gildan Activewear Inc. says its earnings rose in the second quarter as it reaffirmed its full-year guidance after considering the impact of tariffs. The clothing manufacturer, which reports in U.S. dollars, says it earned US$137.9 million in the quarter ending June 29, up from US$58.4 million in the same quarter last year. The Montreal-based company says its adjusted earnings worked out to US$145.9 million, up from US$124.7 million last year. It says adjusted earnings were 97 cents per diluted share, up from 74 cents per diluted share last year. Net sales totalled US$918.5 million in the quarter, up from US$862.2 million in the period last year. Gildan says in reaffirming its guidance after weighing the impact of tariffs along with the options available to it to mitigate the effects, including pricing and its flexible business model. This report by The Canadian Press was first published July 31, 2025. Companies in this story: (TSX:GIL) The Canadian Press Sign in to access your portfolio
